
### [MONDO:0001676](http://purl.obolibrary.org/obo/MONDO_0001676)
**Label:** erythropoietic protoporphyria

**Subclasses:** [MONDO:0008319](http://purl.obolibrary.org/obo/MONDO_0008319) (protoporphyria, erythropoietic), [MONDO:0010420](http://purl.obolibrary.org/obo/MONDO_0010420) (X-linked erythropoietic protoporphyria), [MONDO:0019263](http://purl.obolibrary.org/obo/MONDO_0019263) (autosomal erythropoietic protoporphyria), 

**Corr. equiv. classes:** [OMIM:177000](http://purl.obolibrary.org/obo/OMIM_177000), [OMIM:300752](http://purl.obolibrary.org/obo/OMIM_300752), [Orphanet:443197](http://www.orpha.net/ORDO/Orphanet_443197), [Orphanet:79278](http://www.orpha.net/ORDO/Orphanet_79278), 

**Class expressions from DL-Learner:**

- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0010972](http://purl.obolibrary.org/obo/HP_0010972) (Anemia of inadequate production) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 62.50%
- [HP:0005264](http://purl.obolibrary.org/obo/HP_0005264) (Abnormality of the gallbladder) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 62.50%
- [HP:0001935](http://purl.obolibrary.org/obo/HP_0001935) (Microcytic anemia) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 62.50%
- [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 62.50%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 62.50%


